Variant position: 657 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 770 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human VEPYTKQQLNNMSFAEIIMG YKIMDATNILVSPLVYLYPDI
Mouse VEPYTKQQLNNMSFAEIIMG YKIMDATNILVSPLVYLYPDI
Rat VEPYTKQQLNNMSFAEIIMG YKIMDATNILVSPLVYLYPDI
Pig VEPYTKQQLNNMSFAEIIMG YKIMDATNILVSPLVYLYPDI
Bovine VEPYTKQQLNNMSFAEIIMG YKIMDATNILVSPLVYLYPDI
Chicken VEPYTKQQLNSMSFAEIIMG YKIMDATNILVSPLVYLYPDI
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 770 Signal transducer and activator of transcription 3
580 – 670 SH2
STAT3 mutations in the hyper-IgE syndrome.
Holland S.M.; DeLeo F.R.; Elloumi H.Z.; Hsu A.P.; Uzel G.; Brodsky N.; Freeman A.F.; Demidowich A.; Davis J.; Turner M.L.; Anderson V.L.; Darnell D.N.; Welch P.A.; Kuhns D.B.; Frucht D.M.; Malech H.L.; Gallin J.I.; Kobayashi S.D.; Whitney A.R.; Voyich J.M.; Musser J.M.; Woellner C.; Schaffer A.A.; Puck J.M.; Grimbacher B.;
N. Engl. J. Med. 357:1608-1619(2007)
Cited for: VARIANTS HIES1 GLN-382; LEU-382; TRP-382; LEU-384; SER-384; GLN-423; VAL-463 DEL; ASN-611; VAL-621; ILE-622; LEU-637; MET-637; GLN-644 DEL AND CYS-657;
Functional characterization of two new STAT3 mutations associated with hyper-IgE syndrome in a Mexican cohort.
Alcantara-Montiel J.C.; Staines-Boone T.; Lopez-Herrera G.; Espinosa-Rosales F.; Espinosa-Padilla S.E.; Hernandez-Rivas R.; Santos-Argumedo L.;
Clin. Genet. 89:217-221(2016)
Cited for: VARIANTS HIES1 TRP-382; TYR-395; TYR-425; MET-637 AND CYS-657; CHARACTERIZATION OF VARIANTS HIES1 TRP-382; TYR-395; TYR-425; MET-637 AND CYS-657; PHOSPHORYLATION AT TYR-705 AND SER-727;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.